CrossrefInfokarte
Safety, Pharmacokinetics, and Pharmacodynamics of SHR-2004, a Novel Humanized Monoclonal Antibody Targeting Factor XI, in Patients with Atrial Fibrillation: An Open-Label Phase 1b Study
Clinical Pharmacokinetics · 2026-10-30
DOI: 10.1007/s40262-026-01720-7 ↗Abstract
Kein Abstract verfügbar.
EUVIMED